0000000000681155

AUTHOR

Amelie Elsaesser

showing 2 related works from this author

Influence of respiratory rate and end-expiratory pressure variation on cyclic alveolar recruitment in an experimental lung injury model

2012

Introduction Cyclic alveolar recruitment/derecruitment (R/D) is an important mechanism of ventilator-associated lung injury. In experimental models this process can be measured with high temporal resolution by detection of respiratory-dependent oscillations of the paO2 (ΔpaO2). A previous study showed that end-expiratory collapse can be prevented by an increased respiratory rate in saline-lavaged rabbits. The current study compares the effects of increased positive end-expiratory pressure (PEEP) versus an individually titrated respiratory rate (RRind) on intra-tidal amplitude of Δ paO2 and on average paO2 in saline-lavaged pigs. Methods Acute lung injury was induced by bronchoalveolar lavag…

Time FactorsRespiratory rateSwinePilot ProjectsLung injuryCritical Care and Intensive Care MedicinePositive-Pressure RespirationRandom AllocationRespiratory Ratevarying shunt fractionsAnimalsMedicineddc:610porcine modelcyclic alveolar recruitmentbusiness.industryResearchLung Injuryrespiratory systemrespiratory- dependent paO 2 oscillationsrespiratory tract diseasesPulmonary AlveoliDisease Models Animalacute lung injuryAnesthesiaHigh temporal resolutionIncreased respiratory ratebusinesscirculatory and respiratory physiologyCritical Care
researchProduct

The Changing Landscape for Stroke Prevention in AF: Findings From the GLORIA-AF Registry Phase 2

2017

BACKGROUND: GLORIA-AF (Global Registry on Long-Term Oral Antithrombotic Treatment in Patients with Atrial Fibrillation) is a prospective, global registry program describing antithrombotic treatment patterns in patients with newly diagnosed nonvalvular atrial fibrillation at risk of stroke. Phase 2 began when dabigatran, the first non-vitamin K antagonist oral anticoagulant (NOAC), became available.OBJECTIVES: This study sought to describe phase 2 baseline data and compare these with the pre-NOAC era collected during phase 1.METHODS: During phase 2, 15,641 consenting patients were enrolled (November 2011 to December 2014); 15,092 were eligible. This pre-specified cross-sectional analysis des…

oral anticoagulationCross-Sectional StudieMaleRegistrieFibrinolytic AgentInternationalityAntithrombinMedizinregistryMiddle AgedAntithrombinsDabigatranStrokeProspective StudieCross-Sectional StudiesFibrinolytic AgentsAtrial FibrillationJournal ArticleHumansFemaleProspective StudiesRegistriesCardiology and Cardiovascular MedicineAgedHuman
researchProduct